Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to demonstrate that rivaroxaban is superior to placebo in subjects with HF and significant CAD, who are receiving standard care, in reducing the risk of the composite of ACM, MI, or stroke following an index event.
Critère d'inclusion
- Prevention of death, heart attack and stroke in patients with heart failure and significant coronary artery disease following an episode of decompensated HF (index event)